Commentary · 21 Feb 2026
Conference abstractPublished 15 Sep 2014
In silico screening and docking analysis of few drugs against proteins expressed in colon cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Colon cancer claims a third rank in the list of most common cancers diagnosed in the United States. Literature findings suggest that certain proteins are highly expressed in specific type of cancer. Therefore there a need to discover drugs those are specific against specific proteins in the colon cancer. However most of the anti cancer drugs in the market are known to exhibit severe side effects. Hence new molecules with maximal efficiency of binding towards proteins expressed in colon cancer would be an advantage. Therefore in this study a novel approach has been implemented to screen the existing drugs in the market versus highly expressed proteins in colon cancer and apoptosis. This study revealed five drugs, such as Olmesartan, Verteporfin, Ritonavir, Telmisartan, Eprosartan respectively as probable anti-cancer agents based on the molecular dock scores obtained when compared with bounds ligands of each proteins.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Ravi Vital Kandisa”
- BylineArticles whose byline prints “Narayana Sai Baba KV”
- BylineArticles whose byline prints “P V Varsha”
